Last Price
0.174
Today's Change
-0.028 (13.93%)
Day's Change
0.165 - 0.209
Trading Volume
71,647,083
Exchange: NASDAQ Global Select NASDAQ Global Select
Currency: USD USD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Mr. Timothy Sawyer Mr. Timothy Sawyer
Full Time Employees: 142 142
IPO Date: 1981-07-30 1981-07-30
CIK: 0000352998 0000352998
ISIN: US87960W2035 US87960W2035
CUSIP: 87960W203 87960W203
Beta: 1.62 1.62
Last Dividend: 47.50 47.50
Dcf Diff: -1.02 -1.02
Dcf: 1.33 1.33
Teligent, Inc., formerly Igi Laboratories Inc, is a specialty generic pharmaceutical company. Under the Company's own label, it markets and sells generic injectable pharmaceutical products in the United States and Canada. In the United States it marketed 35 generic topical pharmaceutical products and four branded generic pharmaceutical products, as of December 31, 2018. It provides development, formulation and manufacturing services to the pharmaceutical, over-the-counter (OTC) and cosmetic industries. It focuses on developing, manufacturing and marketing a portfolio of generic pharmaceutical products under its own label in topical, injectable, complex and ophthalmic dosage forms, and managing its contract manufacturing and formulation services business. Its pipeline included 20 Abbreviated New Drug Application (ANDAs) filed with the United States Food and Drug Administration (FDA) for additional pharmaceutical products, as of December 31, 2018.